Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) was the recipient of a large growth in short interest during the month of May. As of May 29th, there was short interest totaling 10,333 shares, a growth of 2,061.7% from the May 14th total of 478 shares. Based on an average trading volume of 67,516 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the company’s shares are short sold.
Raia Drogasil Stock Performance
Shares of RADLY opened at $3.49 on Thursday. Raia Drogasil has a one year low of $2.25 and a one year high of $5.34. The stock has a 50-day moving average of $4.19 and a 200-day moving average of $4.48.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Featured Articles
- Five stocks we like better than Raia Drogasil
- Casey’s Is Looking Like a Hot Buy as Growth, Buybacks, and Guidance Align
- The “Duck Stock” Keeps Quietly Making Money for Shareholders
- As Shares Fall, Analyst Are Boosting their Broadcom Price Targets
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
